Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited has announced the application for quotation of 189,870 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move, involving securities issued under an employee incentive scheme, is part of the company’s strategic efforts to enhance its market presence and operational capabilities.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products designed to improve patient safety and reduce the risk of infection transmission.
Average Trading Volume: 767,482
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.39B
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.